An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Multiple Solid Tumors.

  • Gately, Lucy (Primary Chief Investigator (PCI))
  • Spence, Anne (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date1/05/22 → 31/12/26

Keywords

  • Medical oncology
  • Clinical trial